Search Results - "KONTOGHIORGHES, G. J" :: K.UTB vyhledávací portál

Loading…

Turning a blind eye to deferasirox's toxicity?

by Kontoghiorghes, GJ
Published in The Lancet (British edition) (06.04.2013)

Get full text

Journal Article

Loading…

The Design and Development of Deferiprone (L1) and Other Iron Chelators for Clinical Use: Targeting Methods and Application Prospects

by KONTOGHIORGHES, G. J, PATTICHIS, K, NEOCLEOUS, K, KOLNAGOU, A
Published in Current medicinal chemistry (01.08.2004)

Get full text

Journal Article

Loading…

Effective inhibition of copper-catalyzed production of hydroxyl radicals by deferiprone

by Timoshnikov, V. A., Kobzeva, T., Selyutina, O. Y., Polyakov, N. E., Kontoghiorghes, G. J.
Published in Journal of biological inorganic chemistry (01.05.2019)

Get full text

Journal Article

Loading…

Inhibition of Fe(2+)- and Fe(3+)- induced hydroxyl radical production by the iron-chelating drug deferiprone

by Timoshnikov, V A, Kobzeva, T V, Polyakov, N E, Kontoghiorghes, G J
Published in Free radical biology & medicine (01.01.2015)

Get full text

Journal Article

Loading…

Comparative efficacy and toxicity of desferrioxamine, deferiprone and other iron and aluminium chelating drugs

by Kontoghiorghes, George J.
Published in Toxicology Letters (01.10.1995)

Get full text

Book Review Journal Article

Loading…

Deferiprone versus desferrioxamine in thalassaemia, and T2 validation and utility

by Kontoghiorghes, GJ, Kolnagou, A
Published in The Lancet (British edition) (11.01.2003)

Get full text

Journal Article

Loading…

Iron: Mammalian defense systems, mechanisms of disease, and chelation therapy approaches

by Kontoghiorghes, G.J., Weinberg, E.D.
Published in Blood reviews (01.03.1995)

Get full text

Journal Article

Loading…

Efficacy and possible adverse effects of the oral iron chelator 1,2-dimethyl-3-hydroxypyrid-4-one (L1) in thalassemia major

by AL-REFAIE, F. N, WONKE, B, HOFFBRAND, A. V, WICKENS, D. G, NORTEY, P, KONTOGHIORGHES, G. J
Published in Blood (01.08.1992)

Get full text

Journal Article

Loading…

New concepts of iron and aluminium chelation therapy with oral L1 (Deferiprone) and other chelators : a review

by KONTOGHIORGHES, G. J
Published in Analyst (London) (01.03.1995)

Get full text

Conference Proceeding Journal Article

Loading…

Safety issues of iron chelation therapy in patients with normal range iron stores including thalassaemia, neurodegenerative, renal and infectious diseases

by Kontoghiorghes, G J, Kolnagou, A, Peng, C-T, Shah, S V, Aessopos, A
Published in Expert opinion on drug safety (01.03.2010)

Get more information

Journal Article

Loading…

Transfusional iron overload and chelation therapy with deferoxamine and deferiprone (L1)

by Kontoghiorghes, George J, Pattichi, Katerina, Hadjigavriel, Michael, Kolnagou, Annita
Published in Transfusion science (01.12.2000)

Get full text

Journal Article

Loading…

Deferiprone or fatal iron toxic effects?

by Kontoghiorghes, GJ, Agarwal, MB, Tondury, P, Marx, JJM
Published in The Lancet (British edition) (17.03.2001)

Get full text

Journal Article

Loading…

Serum non-transferrin-bound iron in beta-thalassaemia major patients treated with desferrioxamine and L1

by al-Refaie, F N, Wickens, D G, Wonke, B, Kontoghiorghes, G J, Hoffbrand, A V
Published in British journal of haematology (01.10.1992)

Get more information

Journal Article

Loading…

Long-term trial with the oral iron chelator 1,2-dimethyl-3-hydroxypyrid-4-one (L1). I. Iron chelation and metabolic studies

by Kontoghiorghes, G J, Bartlett, A N, Hoffbrand, A V, Goddard, J G, Sheppard, L, Barr, J, Nortey, P
Published in British journal of haematology (01.10.1990)

Get more information

Journal Article